PW MEDTECH (01358) spent 4.5686 million Hong Kong dollars on repurchasing 3.2 million shares on September 1st.
Puhua and Shun (01358) announced that they will purchase shares for HKD 4.5686 million on September 1, 2025.
PW MEDTECH (01358) announced on September 1, 2025, that it will repurchase 3.2 million shares at a total cost of 4.5686 million Hong Kong dollars, with a repurchase price of 1.4-1.45 Hong Kong dollars per share.
Related Articles
LANCANG TEA (06911): Ms. Huang Lin was elected as an independent non-executive director.
INNOGEN-B (02591) subscription to structured deposit products
NEW WORLD DEV (00017) clarifies the rumors of capital injection, the company has not received any alleged capital injection proposals mentioned in the rumors.
LANCANG TEA (06911): Ms. Huang Lin was elected as an independent non-executive director.
INNOGEN-B (02591) subscription to structured deposit products
NEW WORLD DEV (00017) clarifies the rumors of capital injection, the company has not received any alleged capital injection proposals mentioned in the rumors.
RECOMMEND
The Cost of U.S. Tariffs Has Been Fully Passed On to Consumers! Retail Giants Warn of a New Round of Price Increases
01/09/2025
USD 679 Million in Federal Funding Withdrawn, Multiple Offshore Wind Projects Suspended as U.S. Wind Industry Takes Another Hit
01/09/2025
Huawei Overtakes Apple to Lead Global Smartwatch Market for the First Time
01/09/2025
